Company Filing History:
1 out of 597 
1 out of 6 Years Active: 2023
Title: Inventor Spotlight: Saravana Kanagavelu
Introduction
Saravana Kanagavelu, based in Los Angeles, CA, is a notable inventor whose work has significantly contributed to the biomedical field. With a focus on innovative treatments for muscular dystrophy, he has developed groundbreaking methods that harness advanced cellular therapies.
Latest Patents
Saravana Kanagavelu holds a patent for "Methods and Compositions for Treating Skeletal Muscular Dystrophy". This patent outlines various approaches for treating conditions such as Duchenne muscular dystrophy (DMD) using cardiosphere-derived cells (CDCs). The invention details the administration of these cells either through direct intramuscular injections or systemic intravenous delivery, enabling more effective treatment of dystrophic skeletal muscles. Additionally, his work emphasizes the enhancement of exercise capabilities in DMD patients and explores the innovative use of exosome-mediated transfer of noncoding RNAs to restore dystrophin levels in muscle tissues.
Career Highlights
Throughout his career, Saravana has made significant strides in the field of muscle disease treatment. He has worked with renowned institutions, including Cedars-Sinai Medical Center and Capricor, Inc. His contributions to research and development have positioned him as an expert in cell therapy and regenerative medicine.
Collaborations
Saravana has had the opportunity to work alongside esteemed professionals, including his coworker Mark Amin Aminzadeh. Their collaborations have further advanced the understanding and treatment of muscular dystrophies, pushing the boundaries of current medical practices.
Conclusion
Saravana Kanagavelu's innovative approaches and commitment to improving the lives of those affected by muscular dystrophy mark him as a significant figure in the landscape of biomedical inventions. His patent and collaboration with leading medical institutions underscore the importance of continued research and innovation in the quest for effective treatments.